4-Morpholinopiperidine → HCID 58234941, compound

HRID 1365879Notes

Reaction equation

HRID 1365879 reaction equation
[N:1]1([CH:5]2[CH2:10][CH2:9][N:8]([CH2:11][C:12]3[S:13][C:14]4[N:15]=[C:16]([Cl:27])[N:17]=[C:18]([N:21]5[CH2:26][CH2:25][O:24][CH2:23][CH2:22]5)[C:19]=4[N:20]=3)[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.N1CCC(N2CC[O:37][CH2:36]C2)CC1>>[Cl:27][C:16]1[N:17]=[C:18]([N:21]2[CH2:26][CH2:25][O:24][CH2:23][CH2:22]2)[C:19]2[N:20]=[C:12]([CH2:11][N:8]3[CH2:9][CH2:10][CH:5]([N:1]4[CH2:4][CH2:3][O:37][CH2:36][CH2:2]4)[CH2:6][CH2:7]3)[S:13][C:14]=2[N:15]=1

Participants

3

Reactant 2

HCID 7957244-MorpholinopiperidineHCID 582349332-(4-Azetidin-1-ylpiperidin-1-ylmethyl)-5-chloro-7-morpholin-4-ylthiazolo[5,4-d]pyrimidine

Product 1

HCID 58234941HCID 58234941, compound

Procedure

Prepared according to the method used in the preparation of 2-(4-azetidin-1-ylpiperidin-1-ylmethyl)-5-chloro-7-morpholin-4-ylthiazolo[5,4-d]pyrimidine using 4-piperidin-4-ylmorpholine in place of 4-azetidin-1-ylpiperidine. The title compound was obtained as a white solid (104 mg, 67%).

Workup

  1. customPrepared

Sources & evidence

ORD record
ord-2befaf09f24b498685aeb1150538cca4
Source dataset
uspto-grants-2011_02
Patent number
US07893060B2

Reaction notes

Loading…